scispace - formally typeset
P

Placido Gitto

Researcher at University of Messina

Publications -  11
Citations -  1123

Placido Gitto is an academic researcher from University of Messina. The author has contributed to research in topics: Melatonin & Internal medicine. The author has an hindex of 7, co-authored 8 publications receiving 1050 citations.

Papers
More filters
Journal ArticleDOI

Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin.

TL;DR: It is concluded that treatment with melatonin might result in a wide range of health benefits, improved quality of life and reduced healthcare costs and may help reduce complications in the neonatal period.
Journal ArticleDOI

Causes of Oxidative Stress in the Pre- and Perinatal Period

TL;DR: Evidence continues to accumulate that oxidative stress is a mediator of endothelial dysfunction and thus contributes to the cardiovascular complications of preeclampsia and may play a role in the pathogenesis of a number of diseases in the newborn.
Journal ArticleDOI

Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin

TL;DR: The results indicate that the melatonin may be beneficial in the treatment of newborn infants with asphyxia, and the protective actions of melatonin in this study may relate to the antioxidant properties of the indole as well as to the ability ofmelatonin to increase the efficiency of mitochondrial electron transport.
Journal ArticleDOI

Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin.

TL;DR: Following melatonin administration, nitrite/nitrate levels decreased significantly, whereas they remained high and increased further in the respiratory distress syndrome infants not given melatonin.
Journal ArticleDOI

Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment

TL;DR: Improved survival because of advances in neonatal care has resulted in an increased number of infants at risk for chronic lung disease, and melatonin treatment reduced the proinflammatory cytokines and improved the clinical outcome.